Companhia de Saneamento de Minas Gerais (CSMG3) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Net revenue for Q3 2024 reached R$1.78 billion, up 9.6% year-over-year, driven by tariff adjustments and increased water and sewage volumes.
Adjusted EBITDA grew 13.6% to R$725.7 million, with margin improving to 40.5% from 38.5% in Q3 2023.
Adjusted net income was R$368.3 million, up 9.3% year-over-year, excluding prior year reversals and tax impacts.
Investments in the first nine months of 2024 totaled R$1.56 billion, up 30.7% year-over-year, supporting expansion and modernization.
Regular and extraordinary dividends declared in 2024 totaled R$752.2 million.
Financial highlights
Costs and expenses for Q3 2024 were R$1.21 billion, a 6% increase year-over-year, with manageable costs up 6.8%.
Non-manageable costs increased, mainly due to higher electricity, fuel, and depreciation expenses.
Provision for doubtful accounts rose 65.6% due to a review and recovery of written-off accounts.
Other operational revenues fell 51.8% year-over-year, while other operational expenses surged due to absence of prior year reversals.
CapEx for the first nine months was R$1.56 billion, 30.7% higher than 2023, with 82% of the annual forecast already invested.
Outlook and guidance
Multi-year investment program (2025–2028) targets R$1.97 billion annually to expand water and sewage systems and meet regulatory goals.
Ongoing negotiations with municipalities to extend and rebalance contracts, aiming to mitigate regulatory risks and ensure revenue stability.
Focus on regulatory enhancements to support future tariff cycles and asset base growth.
Expectation of robust investment cycles and regulatory changes to improve shareholder compensation.
Ongoing tariff review process to set new rates effective January 2026.
Latest events from Companhia de Saneamento de Minas Gerais
- Record CapEx, strong financials, and regulatory advances drive robust growth in 2025.CSMG3
Q4 202526 Feb 2026 - Net income up 30.4% and EBITDA margin at 41.4%, with robust investments and higher dividends.CSMG3
Q2 20242 Feb 2026 - Record investments, strong EBITDA, and high dividends highlight robust 2024 results.CSMG3
Q4 202426 Dec 2025 - Record EBITDA, net income, and lowest delinquency rate, with investments up 45.9%.CSMG3
Q1 202526 Nov 2025 - Revenue up, profit down; investments and efficiency gains amid higher leverage.CSMG3
Q2 202523 Nov 2025 - Record CapEx and stable EBITDA margin, with improved leverage and privatization progress.CSMG3
Q3 202513 Nov 2025